Toward a Real-time Access to Sleepers' Mental Content
Launched by ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS · Jul 7, 2022
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how our brains work while we sleep, especially focusing on sleepwalkers. Researchers want to understand the mental processes that happen during sleep, which are often hard to measure. By using sounds to stimulate the brain while participants are in a deep sleep state, they hope to gain insights into memory and how our minds react even when we're not fully awake.
To participate in this study, you need to be between 18 and 35 years old, be a sleepwalker, and provide written consent. The study is currently recruiting participants, and anyone with certain psychiatric or neurological disorders or other sleep issues besides sleepwalking will not be eligible. If you join, you can expect to engage in unique activities that help scientists learn more about sleep and memory. This research could lead to a better understanding of sleep’s role in our overall cognitive health.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age between 18-35 y.o
- • Written consent
- • Affiliated to social security
- • Sleepwalking (group patients only)
- Exclusion Criteria:
- • Psychiatric or neurologic disorder
- • Sleep disorder except sleepwalking for the patient group
- • Surdity
- • Pain or physical disability affecting the upper limbs
- • Consumption of drugs altering sleep structure
- • Subjects under legal protection
About Assistance Publique Hôpitaux De Paris
Assistance Publique - Hôpitaux de Paris (AP-HP) is a leading public hospital system in France, renowned for its commitment to healthcare excellence and innovative medical research. As a prominent clinical trial sponsor, AP-HP plays a pivotal role in advancing medical knowledge and improving patient care through rigorous scientific investigations across a wide range of therapeutic areas. With a focus on collaboration and interdisciplinary approaches, AP-HP leverages its extensive network of hospitals and expert clinicians to facilitate high-quality clinical trials that adhere to the highest ethical and regulatory standards, ultimately aiming to translate research findings into tangible health benefits for diverse patient populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Paris, , France
Patients applied
Trial Officials
Isabelle Arnulf, MD PhD
Principal Investigator
APHP
Delphine Oudiette, PhD
Study Director
Institut National de la Santé Et de la Recherche Médicale, France
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials